These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6682645)

  • 1. Isolated extremity perfusion with DTIC. An experimental and clinical study.
    Aigner K; Hild P; Breithaupt H; Hundeiker M; Schwemmle K; Henneking K; Illig L; Merker G; Paul E; Brodkorb J; Jungbluth A
    Anticancer Res; 1983; 3(2):87-93. PubMed ID: 6682645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanoma.
    Didolkar MS; Jackson AJ; Lesko LJ; Fitzpatrick JL; Buda BS; Johnston GS; Zech LA
    J Surg Oncol; 1996 Nov; 63(3):148-58. PubMed ID: 8944058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New modifications in isolated extremity perfusion ].
    Aigner K; Hild P; Hundeiker M
    Z Hautkr; 1982 Jul; 57(14):1044-54. PubMed ID: 6889794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DTIC in the therapy of solid tumours (author's transl)].
    Kokron O; Pridun N; Zischinsky W
    Wien Klin Wochenschr; 1978 Dec; 90(24):864-7. PubMed ID: 741753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated limb perfusion for stage I melanoma of the extremity: a comparison of melphalan and dacarbazine (DTIC).
    Edwards MJ; Boddie AW; Ames FC; McBride CM
    South Med J; 1989 Aug; 82(8):985-7, 989. PubMed ID: 2762904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DTIC therapy in metastatic malignant melanoma: a simplified dose schedule.
    Pritchard KI; Quirt IC; Cowan DH; Osoba D; Kutas GJ
    Cancer Treat Rep; 1980; 64(10-11):1123-6. PubMed ID: 7459898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional perfusion with cis-platinum and dacarbazine.
    Aigner K; Hild P; Henneking K; Paul E; Hundeiker M
    Recent Results Cancer Res; 1983; 86():239-45. PubMed ID: 6685902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Photosensitization with DTIC therapy in metastatic malignant melanoma].
    Bolling R; Meyer-Hamme S; Schauder S
    Hautarzt; 1980 Nov; 31(11):602-5. PubMed ID: 7451142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional isolated perfusion of high risk melanoma of the extremities with imidazole carboxamide.
    Ariyan S; Mitchell MS; Kirkwood JM
    Surg Gynecol Obstet; 1984 Mar; 158(3):238-42. PubMed ID: 6701736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
    Hauschild A; Garbe C; Stolz W; Ellwanger U; Seiter S; Dummer R; Ugurel S; Sebastian G; Nashan D; Linse R; Achtelik W; Mohr P; Kaufmann R; Fey M; Ulrich J; Tilgen W
    Br J Cancer; 2001 Apr; 84(8):1036-42. PubMed ID: 11308250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activation of dacarbazine (DTIC) for a human tumor cloning system.
    Metelmann HR; Von Hoff DD
    Int J Cell Cloning; 1983 Apr; 1(1):24-32. PubMed ID: 6674387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.
    Weber JS; Zarour H; Redman B; Trefzer U; O'Day S; van den Eertwegh AJ; Marshall E; Wagner S
    Cancer; 2009 Sep; 115(17):3944-54. PubMed ID: 19536884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.
    Breithaupt H; Dammann A; Aigner K
    Cancer Chemother Pharmacol; 1982; 9(2):103-9. PubMed ID: 7172404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
    Rudolf Z; Strojan P
    Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
    Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
    J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
    Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and complications of vascular isolation and hyperthermic perfusion with imidazole carboxamide (DTIC) in melanoma.
    Didolkar MS; Fitzpatrick JL; Jackson AJ; Johnston GS
    Cancer; 1986 May; 57(10):1961-6. PubMed ID: 3955502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.